Acquisition by Alam Kamran of 431000 shares of Taysha Gene at 1.85 subject to Rule 16b-3

TSHA Stock  USD 1.52  0.01  0.65%   
About 62% of Taysha Gene's investor base is looking to short. The analysis of the overall investor sentiment regarding Taysha Gene Therapies suggests that many traders are alarmed. The current market sentiment, together with Taysha Gene's historical and current headlines, can help investors time the market. In addition, many technical investors use Taysha Gene Therapies stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Taysha Gene Therapies Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 431000 employee stock option (right to buy) at 1.85 of Taysha Gene by Alam Kamran on 2nd of January 2025. This event was filed by Taysha Gene Therapies with SEC on 2025-01-02. Statement of changes in beneficial ownership - SEC Form 4

Taysha Gene Fundamental Analysis

We analyze Taysha Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taysha Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taysha Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Taysha Gene is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Taysha Gene Therapies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taysha Gene stock to make a market-neutral strategy. Peer analysis of Taysha Gene could also be used in its relative valuation, which is a method of valuing Taysha Gene by comparing valuation metrics with similar companies.

Peers

Taysha Gene Related Equities

PRLDPrelude Therapeutics   7.02   
0%
91.0%
INZYInozyme Pharma   6.82   
0%
88.0%
HOOKHookipa Pharma   6.37   
0%
82.0%
GOSSGossamer Bio   4.49   
0%
58.0%
STTKShattuck Labs   3.57   
0%
46.0%
DAWNDay One   1.05   
0%
13.0%
GLUEMonte Rosa   0.36   
0%
4.0%
STOKStoke Therapeutics   0.19   
0%
2.0%
AKROAkero Therapeutics   0.08   
0%
1.0%
ALECAlector   1.10   
14.0%
0%
LRMRLarimar Therapeutics   1.38   
17.0%
0%
BMEABiomea Fusion   1.56   
20.0%
0%
CCCCC4 Therapeutics   2.94   
38.0%
0%
TERNTerns Pharmaceuticals   3.02   
39.0%
0%
CABACabaletta Bio   3.47   
45.0%
0%
XFORX4 Pharmaceuticals   7.69   
100.0%
0%

Complementary Tools for Taysha Stock analysis

When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device